What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His main research concerns Lung cancer, Internal medicine, Oncology, Cancer and Carcinoma.
His Lung cancer study integrates concerns from other disciplines, such as Gene expression profiling, Lung, Chemotherapy and Adenocarcinoma.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Surgery.
His Oncology research incorporates themes from Carboplatin, Targeted therapy, Radiation therapy and Disease.
His work carried out in the field of Cancer brings together such families of science as Cancer research and Pathology.
The various areas that Ramaswamy Govindan examines in his Carcinoma study include Positron emission tomography, Nuclear medicine, Proportional hazards model and Database.
His most cited work include:
- Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
- Comprehensive genomic characterization of squamous cell lung cancers (2590 citations)
- Non–Small Cell Lung Cancer (1231 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Oncology, Lung cancer, Chemotherapy and Cancer.
In Internal medicine, Ramaswamy Govindan works on issues like Surgery, which are connected to Gastroenterology.
His Oncology research incorporates elements of Stage, Regimen, Radiation therapy and Disease.
Ramaswamy Govindan focuses mostly in the field of Lung cancer, narrowing it down to matters related to Cancer research and, in some cases, Adenocarcinoma.
Ramaswamy Govindan works in the field of Chemotherapy, focusing on Docetaxel in particular.
Ramaswamy Govindan has included themes like Bevacizumab and Paclitaxel in his Carboplatin study.
He most often published in these fields:
- Internal medicine (62.77%)
- Oncology (55.84%)
- Lung cancer (43.15%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (62.77%)
- Oncology (55.84%)
- Cancer research (16.07%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Oncology, Cancer research, Lung cancer and Cancer.
The concepts of his Oncology study are interwoven with issues in Pembrolizumab, Avelumab, Immune checkpoint and Stage.
His Cancer research study incorporates themes from KRAS, Lung, Mutant and Mutation.
His research in Mutant tackles topics such as Structural variation which are related to areas like Adenocarcinoma.
Ramaswamy Govindan is interested in Non small cell, which is a branch of Lung cancer.
His Cancer research incorporates elements of Computational biology and Gene.
Between 2018 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity (386 citations)
- Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines (166 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Ramaswamy Govindan mostly deals with Cancer research, Internal medicine, Lung cancer, Cancer and Chemotherapy.
His Cancer research research includes themes of Mutation, KRAS, Lung, Small molecule and Immunotherapy.
His Internal medicine research integrates issues from Gastroenterology and Oncology.
His Oncology research is multidisciplinary, relying on both Cancer prevention and Monoclonal.
Ramaswamy Govindan has researched Lung cancer in several fields, including Clinical trial and Intensive care medicine.
His Cancer research includes elements of Gene duplication, Missense mutation and DNA sequencing.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
